Globally, women are roughly twice as likely as men to be diagnosed with thyroid cancer. However, recent research shows that ...

Professor Oliver Bathe urges us to rethink papillary thyroid cancer, noting that “low risk” isn’t always synonymous with low ...

Thyroid cancer is one of the fastest-growing cancers among children and adolescents. New study uncovers troubling link ...

From hormone-disrupting chemicals to chronic stress and genetics, understanding thyroid health is key to preventing ...

The findings add to other research showing a lower risk of obesity-related cancers in patients taking GLP-1 drugs, a class of ...

A recent report found that women account for two-thirds of all cancers diagnosed in people under 50. But it's not all bad news.

The prospect of reducing the risk of some very common cancers adds the weight of evidence behind the GLP-1 agonist class, ...

Researchers conducted a retrospective cohort study to assess the incidence of lymph node metastases among patients with papillary thyroid cancer.

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...

Known for treating children with thyroid disease, cancer and other endocrine disorders, the thyroid center at CHOP is one of the busiest in the U.S.

Thyroid hormone therapy is commonly used to treat conditions where the thyroid gland does not produce enough hormones, such ...

First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of ...